Trail Making Test Could Predict Impairment in Cognitive Domains in Patients with Multiple Sclerosis: A Study of Diagnostic Accuracy
- PMID: 35901460
- DOI: 10.1093/arclin/acac059
Trail Making Test Could Predict Impairment in Cognitive Domains in Patients with Multiple Sclerosis: A Study of Diagnostic Accuracy
Abstract
Objective: Cognitive impairment (CI) and executive dysfunction (ED) are prevalent in patients with multiple sclerosis (PwMS). The Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) is the gold standard neuropsychological battery (NPB) for detecting CI. Delis-Kaplan Executive Function System (DKEFS) NPB evaluates ED. We aimed to find practical test(s) from DKEFS with acceptable diagnostic utility for early detection of impairment in cognitive and executive domains.
Methods: Cognitive and executive tasks, physical disability, and depression scores of 30 PwMS were assessed (17 women, age: 38.1). Symbol Digit Modalities Test (SDMT), Paced Auditory Serial Addition Test (PASAT), and Controlled Oral Word Association Test (COWAT) from MACFIMS and Trail Making Test (TMT), Design Fluency Test (DFT), and Verbal Fluency Test (VFT) from DKEFS were selected. The association between patients' characteristics and performance in tests, and diagnostic accuracy of DKEFS tests in detecting impairment in cognitive tasks were evaluated, using Pearson correlation and receiver operator characteristic curve analyses, respectively.
Results: A significant correlation was found between disease duration and SDMT and TMT subtests. Expanded Disability Status Scale was significantly related to SDMT, VFT-switching, and TMT subtests. Beck Depression Inventory was significantly related to DFT. TMT-switching detected abnormalities in SDMT and PASAT with 100% sensitivity, 93.3% (for SDMT), and 85.7% specificity (for PASAT). TMT-letter showed 100% sensitivity and 90% specificity in identifying abnormalities in COWAT.
Conclusions: TMT, particularly the switching condition, is a practical paper-based test that could predict impairment in cognitive tasks. Clinicians may use TMT as a screening tool among PwMS.
Keywords: Delis–Kaplan Executive Function System; Minimal Assessment of Cognitive Function in Multiple Sclerosis; Multiple sclerosis; Neuropsychological Tests; Symbol Digit Modalities Test; Trail Making Test.
© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.BMC Neurol. 2015 Mar 22;15:40. doi: 10.1186/s12883-015-0296-2. BMC Neurol. 2015. PMID: 25886168 Free PMC article.
-
Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).Clin Neuropsychol. 2016 Oct;30(7):1032-49. doi: 10.1080/13854046.2016.1189597. Epub 2016 Jun 9. Clin Neuropsychol. 2016. PMID: 27279357
-
Comparing cognitive impairment using MACFIMS in patients with multiple sclerosis and healthy controls: a systematic review and meta-analysis.BMC Neurol. 2024 Nov 19;24(1):454. doi: 10.1186/s12883-024-03943-2. BMC Neurol. 2024. PMID: 39563246 Free PMC article.
-
Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).Mult Scler Relat Disord. 2021 Feb;48:102692. doi: 10.1016/j.msard.2020.102692. Epub 2020 Dec 17. Mult Scler Relat Disord. 2021. PMID: 33352358
-
Pharmacotherapy in multiple sclerosis-induced cognitive impairment: A systematic review and meta-analysis.Mult Scler Relat Disord. 2020 Nov;46:102478. doi: 10.1016/j.msard.2020.102478. Epub 2020 Aug 30. Mult Scler Relat Disord. 2020. PMID: 32896820
Cited by
-
Distinct hemodynamic and functional connectivity features of fatigue in clinically isolated syndrome and multiple sclerosis: accounting for the confounding effect of concurrent depression symptoms.Neuroradiology. 2023 Aug;65(8):1287-1300. doi: 10.1007/s00234-023-03174-1. Epub 2023 Jun 10. Neuroradiology. 2023. PMID: 37301785 Free PMC article.
-
Comparing the Efficacy of Two Cognitive Screening Tools in Identifying Gray and White Matter Brain Damage among Older Adults.J Aging Res. 2024 Apr 23;2024:5527225. doi: 10.1155/2024/5527225. eCollection 2024. J Aging Res. 2024. PMID: 38690079 Free PMC article.
-
Mapping cognitive dysfunction in relapsing multiple sclerosis with mild disability: A cross-sectional study from South India.Mult Scler J Exp Transl Clin. 2024 Dec 12;10(4):20552173241304302. doi: 10.1177/20552173241304302. eCollection 2024 Oct-Dec. Mult Scler J Exp Transl Clin. 2024. PMID: 39676817 Free PMC article.
-
Backwards walking speed reserve in persons with multiple sclerosis.Mult Scler Relat Disord. 2024 May;85:105556. doi: 10.1016/j.msard.2024.105556. Epub 2024 Mar 19. Mult Scler Relat Disord. 2024. PMID: 38520947 Free PMC article.
-
Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial.PLoS One. 2024 Feb 13;19(2):e0297235. doi: 10.1371/journal.pone.0297235. eCollection 2024. PLoS One. 2024. PMID: 38349929 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical